Mapping the effectiveness and risks of GLP-1 receptor agonists

https://www.nature.com/articles/s41591-024-03412-w What can’t GLP-1 drugs do? Ziyad Al-Aly led a team trying to compile what he calls an atlas of risks and benefits from the obesity drugs. You’ve heard of health benefits linked to weight loss, like better heart health or diabetes control (the original intent). You may also know people feel the pull of addiction to alcohol or other drugs isn’t so strong. In a large study of VA patients, a new paper out in Nature Medicine Monday found 42 benefits but 19 harms, some of them not familiar. “We tend to think of drugs sort of like they are surgically designed to do only one thing. But the reality is it's almost never like this,” Al-Aly explained. I have more here. What can’t GLP-1s do? Study maps benefits while warning of uncommon risks Atlas of good and bad effects aims to close knowledge gap for blockbuster obesity drugs https://www.statnews.com/2025/01/20/glp-1-drugs-more-than-weight-loss-new-study-42-possible-benefits/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--XahccMtgXVU3JMSaGAG82VCV4jsJT3Bn5YhOww-op5ZhK8mcopboNLfO6x2MBhkPcbcDNIjaCzrrzmngML6dickt04g&_hsmi=343359550&utm_content=343359550&utm_source=hs_email